McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition
Kort samengevat
McKesson Corporation (NYSE:MCK) has agreed to acquire privately held Precision Medicine Group for approximately $2.25 billion, as the healthcare company continues shifting its portfolio toward higher-...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Insider Monkey.
Lees het volledige bericht ↗